Kensuke Tomita
Fortune : 9 M $ au 31/05/2026
Fortune : 9 M $ au 31/05/2026
Kensuke Tomita currently works at ECS Co., Ltd., as Director from 2003.
Mr. Tomita also formerly worked at OncoTherapy Science, Inc., as President & Chief Executive Officer from 2002 to 2011, StemRIM, Inc., as Executive Chairman from 2023 to 2024, and MEDINET Co., Ltd., as Outside Director from 2014 to 2016.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/01/2026 | 5 014 000 ( 8% ) | 9 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
ECS Co., Ltd.
ECS Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Offers consulting services | Directeur/Membre du Conseil | 01/10/1991 |
| Sociétés | Poste | Fin |
|---|---|---|
| STEMRIM | Directeur Général | 25/10/2023 |
| MEDINET CO., LTD. | Directeur/Membre du Conseil | 22/01/2016 |
| ONCOTHERAPY SCIENCE, INC. | Président | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
ECS Co., Ltd.
ECS Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Offers consulting services | Commercial Services |
OncoTherapy Science, Inc.
OncoTherapy Science, Inc. BiotechnologyHealth Technology Engages in the research and development of cancer vaccines and antibody drugs | Health Technology |
MEDINET Co., Ltd.
MEDINET Co., Ltd. BiotechnologyHealth Technology Engages in the contract development and manufacturing organization which provides regenerative medicine & cell therapy services | Health Technology |
StemRIM, Inc.
StemRIM, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of regenerative drugs | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national